Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

VASOTEC

ENALAPRIL MALEATE

Standard Dose
2.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VASOTEC is listed in Drugs@FDA under application 018998 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ENALAPRIL MALEATE Form and strength TABLET;ORAL - 2.5MG Sponsor BAUSCH Submission history Latest submission status date: 2018-08-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview VASOTEC is listed in Drugs@FDA under application 018998 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ENALAPRIL MALEATE Form and strength TABLET;ORAL - 2.5MG Sponsor BAUSCH Submission history Latest submission status date: 2018-08-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.